Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):238-40

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):238-40

DOI: 10.23736/S0031-0808.18.03428-6

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Novel drug delivery approaches in treating pulmonary fibrosis

Kamal DUA 1, 2, 3 , Rajendra AWASTHI 4, Jyotsana R. MADAN 5, Dinesh K. CHELLAPPAN 6, Buchi N. NALLURI 7, Gaurav GUPTA 8, Mary BEBAWY 1, Philip M. HANSBRO 1, 2, 3

1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 2 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 3 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, Australia; 4 NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; 5 Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India; 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia: 7 Department of Pharmaceutics, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India; 8 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, India


PDF


top of page